Radiation Therapy for Head and Neck Cancer - Advanced Cancer Care

Effective Radiation Therapy for Head and Neck Cancer Treatment

Radiation therapy (RT) is a cornerstone of head and neck cancer management. It can serve as a definitive therapy (curative intent, replacing surgery) or as adjuvant therapy (post‑surgery to eradicate microscopic residual disease). Modern high‑precision RT techniques specifically target tumor areas while preserving critical organs such as salivary glands, spinal cord, mandible, and swallowing muscles. RT is particularly indicated for HPV‑positive oropharyngeal cancers, early laryngeal tumors, and nasopharyngeal carcinomas, and is commonly combined with chemotherapy for locally advanced disease. Modern modalities like Intensity‑Modulated Radiation Therapy (IMRT) and Volumetric‑Modulated Arc Therapy (VMAT) achieve tumor control rates of 80–95 % in early‑stage disease with enhanced functional sparing compared with older 2D/3D techniques.

Treatment of Head and Neck Cancer by Radiation Therapy

Systemic Therapies (Complementary to RT)

• •Concurrent chemoradiation (CRT):
  Platinum‑based regimens have improved overall survival in advanced (Stage III–IV) disease by 6–8 %.
• •Induction chemotherapy (TPF):
  Combination of docetaxel, cisplatin, and 5‑FU for tumor downsizing prior to CRT in bulky Stage III or borderline unresectable cases.
• •Immunotherapy combinations:
  PD‑1 inhibitors (pembrolizumab, nivolumab) are under study with RT in high‑risk or recurrent settings for synergistic tumor control and immune activation.

Radiation Therapy (Techniques, Planning, Side‑Effect Minimization)

• •IMRT/VMAT:
  Current standard of care. Precisely conforms radiation dose to target volume, reducing xerostomia risk by 50 % by sparing parotid glands.
• •Image‑Guided Radiation Therapy (IGRT):
  Daily CT‑based guidance ensures millimeter‑level accuracy for mobile head/neck structures.
• •Adaptive RT:
  Re‑planning mid‑treatment mitigates dose deviation from tumor shrinkage or weight loss.
• •Side‑effect minimization measures:
  Dental prophylaxis, prophylactic PEG placement, weekly on‑treatment review by radiation oncologist and the multidisciplinary support team.

Integrative Support (Nutrition, Physiotherapy, Psycho‑Oncology)

• •Nutritional support:
  High‑calorie diet plans and feeding tubes (PEG/NG) for patients projected to lose > 10 % body weight.
• •Speech & swallowing therapy:
  Baseline and weekly exercises prevent aspiration and long‑term dysphagia.
• •Psycho‑oncology counseling:
  Support for treatment fatigue, anxiety, and appearance‑related distress, improving overall adherence and recovery.

Head and Neck Radiation Therapy Guidelines We Adhere To

Principles of NCCN/ESMO Management

• •Stage I–II (early):
  Single‑modality RT (66–70 Gy in 6–7 weeks) or surgery.
• •Stage III–IV (locally advanced):
  Concurrent cisplatin‑based CRT up to 70 Gy; surgery reserved for salvage.
• •Post‑operative setting:
  60–66 Gy for patients with positive margins, ENE, or multiple nodal disease.
• •Reirradiation:
  Used selectively (60–70 Gy with chemotherapy) for isolated recurrences.

How Guidelines Influence Your Plan

Every RT plan at Everhope Oncology follows NCCN v2.2025 compliance with subsite‑specific dose and organ‑at‑risk constraints reviewed in the multidisciplinary tumor board.

Quality Checks & Outcome Tracking

• •Daily image verification (IGRT)
  before treatment
• •Weekly physician review
  for toxicity grading and supportive adjustments
• •Prospective database monitoring
  of swallowing, xerostomia, and local control outcomes

Head and Neck Cancer Radiation Therapy Drugs

Common Drug Classes & Uses

• •Platinum agents:
  Cisplatin (100 mg/m² q3 weeks) or carboplatin when cisplatin‑intolerant.
• •Biologics:
  Cetuximab (400 mg/m² loading → 250 mg/m² weekly) as alternative for cisplatin‑ineligible patients.
• •Supportive:
  Amifostine (radioprotector), pilocarpine (salivary stimulant).

Side‑Effect Management & Supportive Care

• •Mucositis
  Benzydamine rinse, antifungal suspension, topical anesthetics
• •Pain
  Opioid PCA, fentanyl patch
• •Nutrition
  Enteral feeding, enzyme supplementation
• •Skin reaction
  Moisturizing agents (Aquaphor), avoidance of friction/heat

Biosimilars & Access Programs

Everhope assists patients through manufacturer and government‑linked access programs for cetuximab and other systemic agents, ensuring affordability and continuity of treatment.

Types of Head and Neck Cancer Radiation Therapy by Tumor Biology

Get Your Free Cancer Diet Plan & Report Analysis Now on WhatsApp

Talk to experts. Understand your reports. Get a personalized diet plan — all free to start.

Get My Free Plan on WhatsApp

India's First Cancer Care Management Platform

Free to start•Secure & private•No app download needed

HPV‑Positive Oropharyngeal Cancer

• •Favorable biology permits de‑escalation protocols
  (e.g., 60 Gy vs 70 Gy) with > 90 % control rates.
• •Standard regimen for Stage III–IV remains
  70 Gy + concurrent cisplatin.

EBV‑Associated Nasopharyngeal Carcinoma

• •Concurrent + adjuvant cisplatin with 70 Gy RT
  improves survival compared with RT alone.
• •Plasma EBV DNA is used
  for disease monitoring and relapse prediction.

Recurrent/Metastatic Disease

• •Palliative RT:
  Short courses (30 Gy/10 fractions or 8 Gy single fraction) for rapid symptom relief.
• •Reirradiation:
  Stereotactic or brachytherapy boosts in select isolated recurrences.

Why Choose Everhope for Head and Neck Radiation Therapy

Multidisciplinary Tumor Board & Second Opinions

Weekly board reviews every RT plan with ENT surgeons, medical oncologists, radiologists, physicists, pathologists, dietitians, and speech therapists, ensuring consensus on dose, target, and timing.

Evidence‑Based Protocols & Safety

• •Linear accelerators
  with 6‑D positioning and daily CBCT
• •AI‑driven IMRT/VMAT planning
  for homogeneous coverage
• •Motion‑management tools
  minimizing swallowing‑related dose shift

Patient‑Centric Approach & Day‑Care Options

• •Outpatient RT sessions
  (20–30 min/day)
• •In‑house speech and nutrition clinics
  during treatment
• •Rapid‑recovery protocols
  reducing hospital stays

Cost of Head and Neck Radiation Therapy in Gurgaon

What Influences Cost

• •Technique
  (IMRT/VMAT vs conformal)
• •Stage and treatment duration
  (6–7 weeks standard)
• •Concurrent medications
  (cisplatin or cetuximab)

Transparent Estimate Ranges & Packages

• •Early‑stage IMRT
  6–7 weeks, ₹ 2.5 – 3.5 L
• •CRT (Stage III–IV)
  7 weeks, ₹ 5 – 7 L
• •Post‑operative RT
  6 weeks, ₹ 2 – 3 L
• •Palliative RT
  1–2 weeks, ₹ 50 K – 1.5 L

Insurance, TPA & EMI Options

• •Cashless arrangements
  with 25+ insurers
• •EMI plans
  up to 24 months
• •Ayushman Bharat eligibility support
  for select patients

Radiation Therapy Treatment Process at Everhope

• •Step 1 – Consult & Diagnostic Review
  Initial oncology consult and CT simulation for RT planning; Tumor board presentation within 48 hours; Dental evaluation and prophylaxis.
• •Step 2 – Personalised Plan & Consent
  Contouring and dosimetry planning (3–5 days); Documentation of expected toxicities + supportive plan.
• •Step 3 – Therapy Delivery & Monitoring
  Daily 20–30 min sessions (Mon–Fri); Weekly physician evaluation and lab checks; Adaptive re‑planning if anatomical changes occur.
• •Step 4 – Follow‑Up, Survivorship & Rehabilitation
  PET‑CT at 3 months post‑RT for response verification; Speech/swallow therapy begins in Week 3 of RT; Long‑term survivorship clinic for xerostomia, fibrosis, nutrition.